HMS Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.93M Buy
1,666
+9
+0.5% +$10.6K 0.73% 31
2026
Q2
$1.99M Sell
1,657
-33
-2% -$33.7K 0.74% 30
2026
Q1
$1.55M Sell
1,690
-97
-5% -$98.3K 0.6% 36
2025
Q4
$1.92M Sell
1,787
-26
-1% -$24.9K 0.79% 31
2025
Q3
$1.38M Buy
1,813
+195
+12% +$145K 0.58% 41
2025
Q2
$1.26M Sell
1,618
-115
-7% -$89.4K 0.57% 41
2025
Q1
$1.25M Buy
+1,733
New +$1.44M 0.7% 43

Other funds holding LLY

HMS Capital Management's LLY Position: Q3 2026 in Review

HMS Capital Management increased its Eli Lilly (LLY) stake by 0.54% in Q3 2026, buying an estimated $10.6K and bringing the position to 1,666 shares worth $1.93M. The position accounts for 0.73% of the portfolio, ranked #31.

HMS Capital Management first reported a position in LLY in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.99M in Q2 2026. 1,633 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • HMS Capital Management held 1,666 shares of Eli Lilly worth $1.93M as of Q3 2026.
  • HMS Capital Management bought 9 Eli Lilly shares in Q3 2026, an estimated $10.6K.
  • Eli Lilly made up 0.73% of HMS Capital Management's portfolio in Q3 2026, its #31 holding.
  • HMS Capital Management first reported a position in Eli Lilly in Q1 2025 and has held it in 7 quarters since.
  • HMS Capital Management's Eli Lilly position peaked at $1.99M in Q2 2026.
  • 1,633 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on HMS Capital Management's 13F filing for Q3 2026, filed 20 Oct 2026.